Effects of rosuvastatin on atrial fibrillation occurrence: ancillary results of the GISSI-HF trial

Abstract

This study shows that there is some evidence of a beneficial effect of rosuvastatin in terms of reduction of AF occurrence in patients with HF. Larger populations are needed to provide a definite answer to the question. ClinicalTrials.gov Identifier: NCT00336336.